Li-Xin Li, Ya-Wen Wang, Yuan Lin, Yan-Duo Chen, Xu Chen, Xin Li, Xiao-Lin Zhou, Liang Su, Mei-Ying Lin, Kai Zhang
{"title":"乳腺结核伴骨质破坏模仿乳腺癌骨转移:病例报告和文献综述。","authors":"Li-Xin Li, Ya-Wen Wang, Yuan Lin, Yan-Duo Chen, Xu Chen, Xin Li, Xiao-Lin Zhou, Liang Su, Mei-Ying Lin, Kai Zhang","doi":"10.21037/gs-24-185","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis (TB) poses a significant global health challenge. While the incidence of breast TB (BTB) is relatively low, it can easily be mistaken for breast cancer or breast granulomatous lobulitis, potentially delaying timely intervention. The gold standard for diagnosis consists of <i>Mycobacterium TB</i> culture and Ziehl-Neelsen staining. Treatment typically consists of a combination of anti-TB therapy and surgical intervention.</p><p><strong>Case description: </strong>Our research group recently reported a case of BTB accompanied by rib bone destruction. Initially, imaging examinations suggested breast cancer with bone metastasis. However, subsequent real-time ultrasound-guided biopsy revealed chronic inflammation with granulomatous inflammation and extensive necrosis, which led to the diagnosis of BTB. Further T cells spot test (T-SPOT) testing predicted the likelihood of the presence of TB infection, and magnetic resonance imaging (MRI) indicated a high likelihood of TB. A biopsy of the breast lesions was performed and subsequent polymerase chain reaction (PCR) analysis of the aspirated specimens confirmed the presence of DNA from the <i>Mycobacterium TB</i> complex, as well as genes associated with rifampicin resistance. These findings led to the definitive diagnosis of BTB complicated by bone destruction. The patient underwent a 4-month course of anti-TB medication, followed by surgical intervention and an additional regimen of anti-TB drugs. Nine months post-surgery, the patient exhibited no indications of recurrence.</p><p><strong>Conclusions: </strong>The diagnosis of BTB with bone destruction is challenging, and clinicians need to be vigilant not to misdiagnose it as breast cancer or granulomatous lobulitis.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":"13 10","pages":"1853-1862"},"PeriodicalIF":1.5000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558302/pdf/","citationCount":"0","resultStr":"{\"title\":\"Breast tuberculosis with bone destruction mimicking breast cancer with bone metastasis: a case report and literature review.\",\"authors\":\"Li-Xin Li, Ya-Wen Wang, Yuan Lin, Yan-Duo Chen, Xu Chen, Xin Li, Xiao-Lin Zhou, Liang Su, Mei-Ying Lin, Kai Zhang\",\"doi\":\"10.21037/gs-24-185\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Tuberculosis (TB) poses a significant global health challenge. While the incidence of breast TB (BTB) is relatively low, it can easily be mistaken for breast cancer or breast granulomatous lobulitis, potentially delaying timely intervention. The gold standard for diagnosis consists of <i>Mycobacterium TB</i> culture and Ziehl-Neelsen staining. Treatment typically consists of a combination of anti-TB therapy and surgical intervention.</p><p><strong>Case description: </strong>Our research group recently reported a case of BTB accompanied by rib bone destruction. Initially, imaging examinations suggested breast cancer with bone metastasis. However, subsequent real-time ultrasound-guided biopsy revealed chronic inflammation with granulomatous inflammation and extensive necrosis, which led to the diagnosis of BTB. Further T cells spot test (T-SPOT) testing predicted the likelihood of the presence of TB infection, and magnetic resonance imaging (MRI) indicated a high likelihood of TB. A biopsy of the breast lesions was performed and subsequent polymerase chain reaction (PCR) analysis of the aspirated specimens confirmed the presence of DNA from the <i>Mycobacterium TB</i> complex, as well as genes associated with rifampicin resistance. These findings led to the definitive diagnosis of BTB complicated by bone destruction. The patient underwent a 4-month course of anti-TB medication, followed by surgical intervention and an additional regimen of anti-TB drugs. Nine months post-surgery, the patient exhibited no indications of recurrence.</p><p><strong>Conclusions: </strong>The diagnosis of BTB with bone destruction is challenging, and clinicians need to be vigilant not to misdiagnose it as breast cancer or granulomatous lobulitis.</p>\",\"PeriodicalId\":12760,\"journal\":{\"name\":\"Gland surgery\",\"volume\":\"13 10\",\"pages\":\"1853-1862\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558302/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gland surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/gs-24-185\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gland surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/gs-24-185","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
背景:结核病(TB)对全球健康构成重大挑战。虽然乳腺结核(BTB)的发病率相对较低,但它很容易被误诊为乳腺癌或乳腺肉芽肿性小叶炎,从而延误及时干预。诊断的金标准包括结核分枝杆菌培养和齐氏-奈尔森染色。治疗通常包括抗结核治疗和外科干预:我们的研究小组最近报告了一例伴有肋骨破坏的 BTB 病例。最初,影像学检查提示为乳腺癌伴骨转移。然而,随后的实时超声引导活检发现慢性炎症伴肉芽肿性炎症和广泛坏死,从而确诊为 BTB。进一步的 T 细胞斑点测试(T-SPOT)预测了存在结核感染的可能性,磁共振成像(MRI)显示结核的可能性很高。对乳房病灶进行了活检,随后对抽出的标本进行了聚合酶链反应(PCR)分析,证实其中存在结核分枝杆菌复合体的 DNA 以及与利福平耐药性相关的基因。这些结果最终确诊为并发骨质破坏的 BTB。患者接受了为期 4 个月的抗结核药物治疗,随后接受了手术治疗和额外的抗结核药物治疗。术后九个月,患者没有复发迹象:结论:伴有骨质破坏的 BTB 诊断具有挑战性,临床医生需要提高警惕,避免将其误诊为乳腺癌或肉芽肿性小叶炎。
Breast tuberculosis with bone destruction mimicking breast cancer with bone metastasis: a case report and literature review.
Background: Tuberculosis (TB) poses a significant global health challenge. While the incidence of breast TB (BTB) is relatively low, it can easily be mistaken for breast cancer or breast granulomatous lobulitis, potentially delaying timely intervention. The gold standard for diagnosis consists of Mycobacterium TB culture and Ziehl-Neelsen staining. Treatment typically consists of a combination of anti-TB therapy and surgical intervention.
Case description: Our research group recently reported a case of BTB accompanied by rib bone destruction. Initially, imaging examinations suggested breast cancer with bone metastasis. However, subsequent real-time ultrasound-guided biopsy revealed chronic inflammation with granulomatous inflammation and extensive necrosis, which led to the diagnosis of BTB. Further T cells spot test (T-SPOT) testing predicted the likelihood of the presence of TB infection, and magnetic resonance imaging (MRI) indicated a high likelihood of TB. A biopsy of the breast lesions was performed and subsequent polymerase chain reaction (PCR) analysis of the aspirated specimens confirmed the presence of DNA from the Mycobacterium TB complex, as well as genes associated with rifampicin resistance. These findings led to the definitive diagnosis of BTB complicated by bone destruction. The patient underwent a 4-month course of anti-TB medication, followed by surgical intervention and an additional regimen of anti-TB drugs. Nine months post-surgery, the patient exhibited no indications of recurrence.
Conclusions: The diagnosis of BTB with bone destruction is challenging, and clinicians need to be vigilant not to misdiagnose it as breast cancer or granulomatous lobulitis.
期刊介绍:
Gland Surgery (Gland Surg; GS, Print ISSN 2227-684X; Online ISSN 2227-8575) being indexed by PubMed/PubMed Central, is an open access, peer-review journal launched at May of 2012, published bio-monthly since February 2015.